ALBERTI, CLAUDIA
ALBERTI, CLAUDIA
Universita' degli Studi di MILANO
Investigating the role of serum NfL, FGF21, NCAM1 and GDF15 as disease biomarkers for Charcot-Marie-Tooth type 2A
2026 E. Abati, D. Saccomanno, C. Alberti, A. Anastasia, D. Gagliardi, E. Ferri, B. Arosio, G. D Angelo, R. Cima, M.T. Bassi, S. Oldoni, G.P. Comi, P. Rizzo, S.P. Corti
RNA biomarkers in spinal muscular atrophy: enhancing pathogenesis understanding and guiding precision medicine
2026 C. Alberti, A. Berardinelli, G.P. Comi, L. Ottoboni, S. Corti
From molecular convergence to clinical divergence: Comparative pathogenic mechanisms and therapeutic trajectories in C9orf72-ALS/FTD and myotonic dystrophy
2025 C. Alberti, V. Parente, S. Corti, V.A. Sansone
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives
2024 C. Alberti, F. Rizzo, A. Anastasia, G. Comi, S. Corti, E. Abati
Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy
2024 E. Abati, C. Alberti, V. Tambè, A. Esseridou, G.P. Comi, S. Corti, G. Meola, F. Secchi
A rare association of Guillain-Barré syndrome/Miller-Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor?
2024 C. Alberti, N. Molitierno, V. Iacobelli, D. Velardo, G.P. Comi, S. Corti, M. Parisi, E. Abati